DiaMedica Therapeutics Inc.
DMAC
$6.05
$0.091.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.51M | 2.60M | 2.19M | 2.49M | 1.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.21M | 9.03M | 8.01M | 8.14M | 8.42M |
| Operating Income | -9.21M | -9.03M | -8.01M | -8.14M | -8.42M |
| Income Before Tax | -8.73M | -8.61M | -7.69M | -7.70M | -7.89M |
| Income Tax Expenses | 10.00K | 6.00K | 6.00K | 6.00K | 9.00K |
| Earnings from Continuing Operations | -8.74M | -8.62M | -7.70M | -7.71M | -7.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.74M | -8.62M | -7.70M | -7.71M | -7.90M |
| EBIT | -9.21M | -9.03M | -8.01M | -8.14M | -8.42M |
| EBITDA | -9.20M | -9.02M | -8.00M | -8.13M | -8.41M |
| EPS Basic | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.11 | -0.11 | -0.12 |
| EPS Diluted | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.11 | -0.11 | -0.12 |
| Average Basic Shares Outstanding | 52.42M | 49.63M | 42.96M | 42.84M | 42.81M |
| Average Diluted Shares Outstanding | 52.42M | 49.63M | 42.96M | 42.84M | 42.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |